close
MENU
Hot Topic Hawke’s Bay
Hot Topic Hawke’s Bay
General Business
6 mins to read

Cannabis start-up investors in the dark on failed $180m deal

A $180 million deal with Rhizo Sciences is up in smoke but PlegeMe investors haven't been told.

Dane Ambler Tue, 06 Nov 2018

Medicinal cannabis start-up Hikurangi Enterprises denies it counted its seedlings before they flowered when it lured unwitting investors in on the basis of a deal that hasn't gone ahead.

The Ruatoria-based company, which was the first in New Zealand to secure a licence to cultivate medicinal

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Contact the Writer: dane@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Cannabis start-up investors in the dark on failed $180m deal
General Business,
77102
true